In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it [...]
A large UK study suggests that people who use cannabis to self-medicate for pain or anxiety may be more likely to experience paranoia, prompting calls for improved patient monitoring in private prescribing. Researchers from King’s College London recently published the first findings from the Cannabis & [...]
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? In the face of long NHS waiting lists and a lack of options in mainstream healthcare, [...]
Families have marked the seventh anniversary of the legalisation of medical cannabis in the UK with further calls for urgent government action on NHS access. Dozens of families attended Westminster on Tuesday (4 November) to meet with cross-party MPs and demand immediate action to address the [...]
The endocannabinoid system (ECS) helps regulate vital bodily functions from mood and pain to immune response, yet it remains one of medicine’s best-kept secrets. We unpack the science behind the ECS and its significance in a range of chronic conditions. The endocannabinoid system (ECS) plays a [...]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in reducing illicit sales and promoting safer consumption. The move comes as the Swiss Federal Government continues [...]
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development (CPD)-accredited event, meaning attendees can earn professional development credits as a result of their participation. The [...]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it [...]
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) Specialist Register have the training required to prescribe medical cannabis. While the UK’s medical cannabis market [...]
A growing number of patients are now prescribed medical cannabis for common mental health issues and neurodiverse conditions, such as autism and ADHD. Ahead of Cannabis Health Symposium next month, we examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry. Many [...]
Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025 at Conway Hall, London. The event, delivered in partnership with the Medical Cannabis Clinicians Society (MCCS), will focus on strengthening clinical understanding and confidence in prescribing [...]
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in [...]
How one oncologist is helping redefine patient care and the future of integrated healthcare. Medical cannabis is starting to have a very different kind of conversation in the UK. From mainstream voices like Rory Cellan-Jones exploring patient experiences on his Movers & Shakers podcast, to growing [...]
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an investment of over $250m, its VER-01 chronic pain-relief drug has passed a Phase 3 trial in its home market. As [...]
As the prevalence of dementia and other neurodegenerative conditions continues to rise globally, there is growing interest in the role of cannabis-based medicines in symptom management. A small number of studies, combined with real-world clinical experience is beginning to provide important insights into the potential of [...]
Medical cannabis patients will host a major educational event in the UK next month, aiming to bridge the gap between patients and healthcare professionals through evidence, empathy and lived experience. The international patient-led organisation We, The Patients, will bring its educational series to London next month [...]
Experts say real-world evidence could offer crucial insights into how these medicines work in practice, and help widen access for patients. For the last 50 years, randomised controlled trials (RCTs) have been considered the ‘gold standard’ research methodology for measuring the safety and efficacy of new [...]
In a historic move, Spain’s Council of Ministers has approved a long-awaited Royal Decree regulating the medicinal use of cannabis preparations in hospital settings. Following years of advocacy on behalf of patients and campaigners, the decision marks a decisive step toward the integration of medical cannabis [...]
Germany’s booming cannabis market, which Prohibition Partners now estimates to be worth around €670m, is entering uncertain and potentially treacherous territory. As the landmark CanG Act approaches its second year, it has become a highly charged and increasingly divisive issue politically, culturally, and medically. With the [...]
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on the quality of care. When people talk about growth in healthcare, the conversation often centres on numbers – the number [...]
New guidelines around THC levels, dosages, and eligibility, aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK. Almost seven years since medical cannabis was legalised in the UK, around 180 specialist consultants are now actively prescribing. But almost [...]
Words by Lawrence Purkiss and Sarah Sinclair Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week, amid a growing feeling that the country – a once-thriving hub for European cannabis exports – is at an inflection point. Discussion among speakers [...]
By Rupa Shah, Head of Compliance at Releaf The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK. Despite the fact that thousands of patients now access cannabis-based medicines legally through prescription, the framework remains poorly understood by [...]
Mental health advocate and one half of music duo Rizzle Kicks, Jordan Stephens, is collaborating with medical cannabis clinic, Alternaleaf, to shed light on the role of alternative treatments in supporting mental wellbeing. Stephens, who is currently touring with Rizzle Kicks as part of their comeback [...]
The UK’s medical cannabis industry is now the second largest in Europe, second only to Germany, thanks to consistent and sustained growth over the last seven years. While this has seen thousands of new patients gain access to medical cannabis, it still represents just a fraction [...]
A Yorkshire man, who supplied cannabis products to thousands of people with chronic illnesses, has been jailed for four years after his original suspended sentence was overturned. Joel Cunningham, 40, from Leeds, was convicted of seven offences, including possession with intent to supply magic mushrooms and [...]
Cannabis Health has partnered with leading experts at the Medical Cannabis Clinicians Society (MCCS) to bring its first educational event for healthcare professionals to the UK later this year. The Cannabis Health Symposium, taking place at Conway Hall in London on 25 November, 2025, will welcome [...]
New analysis has found that NHS access to medical cannabis could boost the UK’s economy by £13.3 billion over the next decade by returning thousands back to work. Widening NHS access to medical cannabis could add £4.5 billion to the economy over five years, and £13.3 [...]
A major new study, analysing data from over four million adults in the US and Europe, has linked cannabis use to an almost quadrupling in the risk of developing type 2 diabetes. Cannabis use is increasing globally with an estimated 219 million users (4.3% of the [...]
Two new studies, one a large meta-analysis and the other real-world evidence from the UK, suggest that cannabis-based medicines, particularly those containing THC or mixed cannabinoids, may improve sleep quality and ease symptoms of insomnia. A new systematic review and meta-analysis, published in the journal Sleep [...]
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval process. Yesterday, the Food Standards Agency (FSA) announced that its 12-week public consultation to discuss the [...]
Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, the device offers patients a precise, discreet, and clinically approved way to inhale cannabis-based treatments. Since [...]
Cannabis Health will host its first expert-led educational event for healthcare professionals later this year, with a focus on bridging the gap between policy and patient access. The one-day, CPD-accredited Cannabis Health Symposium, taking place at Conway Hall in London on Tuesday 25 November, 2025, is [...]
Despite a slow start in facilitating patient access to medical cannabis treatments, this is gradually changing for the better. The UK now has an active patient base of approximately 50,000-60,000, and an estimated 80,000 individuals are expected to receive treatment with CBPMs throughout 2025. The CQC [...]
Scientists in South Africa say they have found the first evidence of a rare class of phenolics, called ‘flavoalkaloids’, in leaves from the cannabis plant. Phenolic compounds, especially flavonoids, are well-known and sought after in the pharmaceutical industry because of their antioxidant, anti-inflammatory, and anti-carcinogenic properties. [...]
A new review has found ‘consistent evidence’ that cannabis improves sexual function in women, and should be considered as a first-line treatment for patients with female orgasm disorder (FOD). After reviewing findings from 16 peer-reviewed studies, including data from over 8,000 women, researchers have formally recommended [...]
A UK medical cannabis clinic is carrying out investigations after a substantial amount of patients’ information was leaked in a major data breach. In an email sent to patients on Monday 18 August, CB1 Medical confirmed it had identified a ‘data security incident’ when patients’ personal [...]
A new survey of NHS doctors has highlighted a growing demand for alternative treatment options for complex health issues such as chronic pain and women’s health-related concerns. Out of 500 doctors currently practicing in the NHS, almost half of which were GPs, three quarters said that [...]
Ireland has become the latest jurisdiction to ban the use of the semi-synthetic cannabinoid HHC, with ministers raising concerns related to growing use among young people and risks to mental health. The decision, announced by the Department of Health on 29 July, sees Hexahydrocannabinol (HHC) classified as [...]
New research on a large data set of older adults suggests cannabis use may be linked to slower brain ageing and improved cognitive function. The study, which used data collected from 25,000 adults aged between 44 and 81 years, found that those who had consumed cannabis [...]
A new study is the first to confirm a link between an invasive fungal infection and a medical cannabis product sold to a patient in the US. A cancer patient, using medical cannabis to manage the side effects of chemotherapy, developed a life-threatening fungal infection after [...]
Just months ago, France’s long battle to establish a permanent generalised medical cannabis framework was on the brink of failure. Despite other major European countries looking to France’s 2019 pilot scheme for inspiration, COVID-19, waning political will, operational hurdles, and the dissolution of the National Assembly [...]
A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with cannabis use disorder (CUD) are more than three times more likely to develop oral cancer within five years compared to those without CUD. In 2022, 17.7 [...]
The Care Quality Commission has raised a number of concerns related to the prescribing of cannabis-based products for medicinal use in the UK, as the latest data reveals further increases in private prescriptions. Earlier this month the independent regulator which is responsible for overseeing health and [...]
An international survey of people living with eating disorders has found that cannabis and psychedelics, such as ‘magic mushrooms’ or LSD, were best rated as alleviating symptoms by respondents who self-medicated with the non-prescribed drugs. The worst-rated drugs were alcohol, tobacco, nicotine and cocaine. Meanwhile, prescribed [...]
The European medical cannabis sector is experiencing unprecedented growth, driven by progressive legislation, expanding patient access, and a maturing supply chain, according to a new report. Findings from The European Cannabis Report: 10th Edition, published today (Tuesday 29 July), reflect a decade of immense change across European [...]
Current methods used by police to detect drug driving are not based on science, say the authors of a new paper calling for an overhaul of cannabis impairment testing. As cannabis becomes legal in a growing number of US states, public safety experts have raised concerns [...]
In a special edition of the Business of Cannabis Podcast, we go from ‘anecdote to evidence’ with Dr Anne Katrin Schlag, Head of Research and Interim CEO at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move [...]
Over four years after its slated launch, the NHS Cannabis Patient Registry is set to publish its first data. The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end [...]
By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s medical cannabis sector, building a clinical team isn’t just operational work, it’s mission-critical. With the field [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
